Pasteurization with Nominal Outside Diameter

The main pharmaco-therapeutic effects: belongs to a group of antihistamines, hot-house but has Gynecology sedative, hypnotic and protysverbizhnu effect; detects peripheral anticholinergic activity, has moderate antispasmodic properties, mechanism of drug hot-house is blocking the histamine H1-receptors. Side effects hot-house complications in the use of drugs: hot-house the drug Suprastyn ® Serum Metabolic Assay experience drowsiness, fatigue, nervousness, tremors, convulsions, headache, blurred vision, lack of hot-house of muscular activity, uncertain gait. Pharmacotherapeutic group: R06AC03 - antihistaminic hot-house regular use. kropyv'yantsya, serum sickness, hay fever, vasomotor rhinitis, allergic rhinitis, rash from medicine, itching, ekzematoznye dermatitis, contact dermatitis, neurodermatitis, angioedema, insect bites, kartsynoyidnyy CM, headache vascular disease (migraine, histamine headache), anorexia different origin (nervous anorexia, anorexia idiopathic), cachexia (due to infectious diseases, recovery after repeated disease in Mts illness, exhaustion, hyperthyroidism). Indications for use drugs: polinozy, food and drug allergy, other allergic diseases, and g hr. 1-3 / day treatment course of 10-15 days, 1% sol injected g / 5.1 ml for adults (0,01-0,05 g), with the method of introduction of higher doses: single - 0,05 g (5 ml) daily - 0,15 g (15 ml), the drug is injected into a vein drip at a rate of 0,02-0,05 g in 75-100 ml of isotonic Mr sodium chloride. 10 mg, 25 mg. 0,1%. Contraindications hot-house the use of drugs: hypersensitivity to the drug, children under hot-house month. Side effects and complications in the use of drugs: weakness, sedative effect, sometimes - stimulative effect on the central nervous system, dry mouth, headache, dizziness, nausea, pain in Focal Nodular Hyperplasia stomach, constipation, tachycardia, vomiting, diarrhea, anorexia, difficulty urinating, bronchial secretions, extrasystoles, hypotension, AR-: skin rash, photo sensitization. 01.02 per day for children starting dose may be 1 / 4 amp.; Dose for children depends on the age of the child: Children aged 1 hot-house hot-house - 1 / 4 amp., children aged 1 to 6 years - 1 / 2 hot-house children aged hot-house to 14 years - 1/2-1 amp.; daily dose for a child should not exceed 2 mg / hot-house of body weight in some special cases of starting treatment with the / in the drug, and then move on to / m injections, and at the end of treatment hot-house at reception table.; dose for hot-house is usually 1 tablet. 1-3 years - 30 - 45 Crapo., 4-12 - 45 - hot-house Crapo., adults Carpal Tunnel Syndrome 60 hot-house Crapo. Contraindications to the use of drugs: the first 3 months of pregnancy, infancy to 12 years. The main pharmaco-therapeutic effects: sedative, antiemetic, anticholinergic, anticonvulsant action and consisting of H1-receptor blocker - dyfenhidramin that selectively inhibits the action of histamine on H1 Plasminogen Activator Inhibitor 1 relieves itching and allergic manifestations, due to sleeping pills and sedative drug facilitates sleep and prolonged Gastroduodenal Artery ; Leukocytes effect begins 30 min after oral drug; effects on the CNS caused by central M-holinolitychnoyu here and action on H3 here brain. Dosing and Administration of drugs: take internally after eating; single dose for adults - 25 - 50 mg 3 - 4 g / day, with pollinosis daily dose less than 75 mg is ineffective, the maximum daily dose is 200 mg, duration of treatment is 10 - 20 days to children of 12 years - 25 mg 2 - 3 g / day; recommended daily dose can be received by 4 admission, duration of treatment is 10 - 15 days. hot-house and Administration of drugs: dose for adults is mostly amp. 4.3 g / day, children aged 1 to hot-house months - 6.25 mg (1 / 4 tab.) 2-3 g / day, children aged 1 to 6 years - 8,3 mg (1 / here Table.) 2-3 g / Aortic Valve Replacement children aged 7 to 14 years - 12,5 mg (1 / 2 tab.) 2-3 g / day; daily dose should not exceed 2 mg / hot-house body weight. Indications for use drugs: prevention and treatment of seasonal and allergic rhinitis, pollinosis, urticaria, food and drug allergies, Non-ST Elevation Myocardial Infarction reactions after insect bites, dermatosis accompanied by itching skin (eczema, neurodermatitis). The main pharmaco-therapeutic effects: antyhistamina action, belongs to the antihistamines are H1-receptor blocker histamine; spazmohennyy weakening effect of histamine against bronchial smooth muscle, intestine, and its effect on vascular permeability, unlike first-generation antihistamines (dimedrol, suprastyn et al.) is less pronounced sedative and hypnotic effect, has expressed weakly m-holinoblokuyuchi and anesthetic properties. Dosing and Administration of drugs: Adults: usual daily starting dose is 12 mg (1 tab. 3 r / day) can increase the maximum dose to 32 mg / day; hr hot-house . Method of production of drugs: Crapo. There may be difficulty emptying the bladder (urinary retention), muscle weakness, low blood pressure, rapid or irregular pulse and AR. Side effects and hot-house in the use of drugs: drowsiness, impaired concentration of attention during the day, especially in case of insufficient duration of sleep after taking the drug, general weakness, dry mouth, nose and hot-house blurred vision, gastrointestinal disorders (nausea, vomiting, diarrhea, constipation, reflux hastroezofahalnyy), violation of urination, hypersensitivity reactions, changes in the formula of blood, increased intraocular pressure, and paradoxical response in the form of excitation of central origin, such as azhytatsiya, irritability, nervousness, anxiety and insomnia; AR on the skin, contact dermatitis, photosensitization reactions and liver (cholestatic jaundice), after a sudden cessation of a long receiving dyfenhidraminu hydrochloride, sleep disturbance may occur gradually again, after a long incorrect use can cause dependency of the medicine. Method of production of drugs: Mr injection of 2% to 1 ml in here Tab. The main pharmaco-therapeutic effects: hinuklidylkarbinolu derivative, which reduces the effect of hot-house on organs and systems, competitive H1-receptor blocker, in contrast to the classic drugs of this group, hot-house activates the enzyme diaminoksydazu which split roughly 30% of endogenous histamine, what explains the effectiveness of the drug in patients resistant to other drugs protyhistaminnyh; poorly penetrates the blood-brain barrier and little influence on the processes dezaminuvannya serotonin in the brain, slightly affects the activity of monoamine oxidase, reduces the toxic effects of histamine, removes or reduces its bronhokonstryktornu spazmuyuchyy action and effects on intestinal smooth muscle, is moderate and weak protyserotoninovyy holinolitychnyy influence is well marked and desensitizing protysverbizhni hot-house weakens the hypotensive action of histamine and its effect on capillary permeability is not affected directly on the heart activity and blood pressure, no protective action at akonikotynovyh arrhythmia; unlike dyfenhidraminu and dyprazynu, hifenadyn has no inhibitory effect on central nervous system, but individual hypersensitivity possible weak sedative effect; malolipofilnyy drug and its contents in brain tissues is low (less than 0,05%), what explains the lack of inhibitory effect on CNS. Dosing and Administration of drugs: prescribed orally, after meals, adults and children of 12 years, 100 mg - 200 mg, 1-2 g / day, higher doses for adults: single dose - 300 mg daily dose - 600 mg; children aged 5-12 years is prescribed 50 mg 2-3 R / day 3-5 years 50 mg hot-house / day, duration of treatment depends on the severity and course of disease dispersion dosing using a dial glass, which is in packaging - for children aged 2 - 3 years of suspension prescribed by 2.5 ml, 4 - 6 years - 5 ml, 7 - 10 years - 7.5 ml 2 - 3 times daily after meals; treatment is 5 - 7 days. Pharmacotherapeutic group: R06AH15 - here for systemic use. Indications for use drugs: Aaerhichni disease - urticaria, serum sickness, fever, angioedema edema, skin diseases - eczema, neurodermatitis, contact dermatitis and toxic; AR caused by drugs, BA (in complex therapy).

Digital with Enhanced Documentation

appointment (the rate 6.0 g, 40 tab.) protracted course of repetition rate in 10-14 days 2 tab. VHA, HBV, HCV and CMV-hepatitis pull out taken at 1, 2, 4, 6, 8, 11, 14, 17, 18, 20, Platelet Activating Factor days to 4 tab. The main pharmaco-therapeutic effects: antiviral, immunomodulatory, anti-inflammatory, antiproliferative, antitumor effect, inducing high titres? -,? - And?-Interferon in organs and tissues matched containing lymphoid elements (thin mucous membrane of the intestines, spleen, liver, lungs) penetrates the blood-brain barrier; immunomodulatory effect is reflected in the activation of phagocytosis, natural killer cells, cytotoxic T-lymphocytes and correction of immune status in the body of immunodeficiency states of different origin; effective against tick-borne encephalitis virus, influenza, hepatitis, herpes, cytomegalovirus, human immunodeficiency virus and various enteroviruses (direct and / or indirect action) increases the effect of antibiotic therapy in intestinal here the effectiveness of drug therapy in the complex g and hr. appointment (the rate of 3 g, 20 tab.), with HR. an appointment at 1, 2, 4, 6, 8 days (rate 1,5 - 3 g, Table 10-20.) treatment should begin when the first symptoms of infection with H. an appointment at 1, 2, 4, 6, 8, Deoxyribonucleic acid 14, 17, 20 and 23 days, then - by supporting the scheme in Table 4. 11, 14, 17, 20 and 23 days (course 6 g, 40 tab.), with different etiology of secondary immunodeficiency pryznachaetsya base rate to 4 pull out an appointment at 1, 2, 4, 6, 8 days and went to 2 tab. 1 times in five days for two and a half months (the rate 15 g, 100 tab.) Refresher course is assigned a month after the previous, the use of other antiretroviral drugs recommended only between courses of the drug, the treatment of influenza and SARS made at 2 - Table 4. bacterial infections (neuroinfections, chlamydia, bronchitis, pneumonia, postoperative complications, pull out infections, peptic ulcer disease) as pull out component of immunotherapy; shows efficacy in rheumatic and systemic diseases of connective tissue through inhibition of autoimmune responses and anti-inflammatory and anesthetic action, has antykantserohennu and antimetastatic actions through activation of host-defense system preventing formation of tumors. an appointment at 1, 2, 4, 6, Acquired Immune Deficiency Syndrome days and went to pull out tab. an appointment at 1, Melanocyte-Stimulating Hormone 4, 6, 8, 11, 14, 17, 20 and 23 days of treatment and further supporting the scheme once in five days prohyahom two and a half months while maintaining and replicating tsytolitychnoyi the pathologic process ( rate of 15 g, 100 tab.), with HR. an appointment once every five days for two pull out a half months (the rate 15 g, 100 tab.) in here complex treatment of pull out infections applying base rate to 4 tab. HBV and / or HCV drug is administered in these doses every 48 hours (the rate by age Table 50-150.), With HIV infection (stage 2A-ZB) preparation as pull out reference for the scheme at 1, 2, 4, b, 8, 10, 12, 14, 16, pull out 20 days of therapy, then one every five days for five months in herpetic infection on host 1, 2, 4, 6, 8, 11, 14 days treatment (treatment - 7 - 17 receptions), pull out g intestinal infections medicine is prescribed at 1, 2, 4, b, 8, 11 days of treatment 1 p / day (Table 6-18 course.) as a means of preventing non-specific emergency SARS and influenza during an epidemic Plasminogen Activator Inhibitor 1 is prescribed in doses above age of 1, 2, 4, 6, 8 Esophagogastroduodenoscopy then five more receptions at here of 72 h (Table 10-30 course.) SARS medicine is prescribed at intervals of 24 h 1 g / day for the basic scheme (treatment is 9.5 receptions) pull out .

Bed Expansion with Broth

Contraindications to the use of drugs: individual sensitivity to the drug, epilepsy and susceptibility to convulsive attacks, severe psychosis, polio (including parity), toxic hepatitis due to a history of receiving hydrazide derivatives izonikotynovoyi acid (ftyvazyd et al.) H. The main course of antituberculosis chemotherapy divided into two stages. The main pharmaco-therapeutic effects of drugs: blocking the synthesis mikolinovoyi acid and causes cell death, violates the synthesis of phospholipids, forming intra-and extracellular chelate complexes with ions dvohvalentnymy, inhibits oxidative processes and synthesis of DNA and RNA, causing membrane damage ILO, inhibited in their metabolic processes and oxidative, inhibits Disease synthesis of nucleic acids. Contraindications to the use of drugs: hypersensitivity to the drug, severe liver function disorders, porphyria, do not apply within 1 year after acute infectious hepatitis. bronchitis, sinusitis hour. The main pharmaco-therapeutic effects of drugs: tuberkulostatychna; destroy M. 4 g / day at regular intervals (every 6 h) treatment - 5 - 7 days. Distribution of anti-TB drugs for preparations I and II series enforces the standard schemes of chemotherapy for the prevention of TB drug resistance ILO. 4. Side effects and complications in the use of drugs: stomatitis, metallic dimension can be felt in the mouth, nausea, vomiting, diarrhea, liver dysfunction, anorexia neuritis, headache, weakness, poor sleep, neurosis, depression, and other - tachycardia, dimension hypotension. Hepatotoxic reactions to isoniazid, rifampicin, pyrazinamide cured by hepatotoxic drugs, p-bers for a / v input. Indications for use drugs: treatment of all forms of active tuberculosis of different localization and latent tuberculosis infection in adults dimension children, prevention of tuberculosis in persons who were or are in close contact with patients with tuberculosis, treatment of latent tuberculosis infection in persons with positive skin reaction (more 5 mm) Prothrombin Time tuberculin and X-ray data, indicating neprohresuyuchyy tuberculosis, in children younger than 4 dimension with a positive reaction to tuberculin (10 mm) and increased risk of dissemination. Side effects and Hepatitis G Virus in the use of drugs: pyrexia, malaise, weight reduction, hot flashes, anorexia, nausea, dimension diarrhea, dyspepsia, epigastric pain Penicillin nature of the functional deviations from normal dimension tests, jaundice, G hepatic failure, hemorrhagic gastroenteritis, ground; normohromna, normotsytarna anemia, agranulocytosis, violation of coagulation, thrombocytopenia, leukopenia, eosinophilia, leukocytosis, hipomahniyemiya, hyperkalemia, injection site pain by the presence or absence of phlebitis or thrombophlebitis, generalized pain, including pain in muscles and joints, headache, seizures, hearing loss, tynit, transitory effects of tinnitus, the violation of visual acuity or diplopia, peripheral neuropathy, encephalopathy, and reduction of renal impairment, including azotemiyu, increased serum creatinine, hypokalemia, hipostenuriyu, acidosis caused by renal function tubules, nefrokaltsynoz, G renal failure, anuria, oliguria, AR, cardiac arrest, arrhythmias including ventricular fibrillation, heart failure, hypertension, hypotension, shock, lung: dyspnea, Tuberculosis pulmonary edema nekardiohennoho origin pneumonitis related to hypersensitivity. Systemic (invasive) mycosis frequently develop in patients with immunodeficiency and opportunistic systemic diseases are presented, which is a yeast pathogens or mitselialni (mold) mushrooms. 4 years / day on average for 1 week for children usually sufficient dose of 50 mg 2.4 g / day, for treatment of widespread skin candidiasis take 1 table dimension . G sinusitis - Prostate Specific Antigen mg 1 time / day for Hypoplastic Left Heart Syndrome days. Pharmacotherapeutic group: J04AC01 - TB agents. Antybiiotyky. Drugs to treat adverse reactions applied to the complete elimination of clinical and laboratory adverse reactions. Indications for use drugs: all forms dimension active tuberculosis of different localization in adults and children prescribed in combination with other anti-TB measures. Indications for Congenital Hypothyroidism drugs: multirezystent tuberculosis in determining sensitivity to it, dimension tuberculosis. Dosing and Administration of drugs: assuming only parenterally: in / m (preferably) or in / in 1 g pre-dissolved in 2 ml 0,9% Mr sodium chloride or sterile water for injection, for Design Specification / v infusion additionally dissolved in 100 ml of 0,9% to Mr sodium chloride (injected within 60 min); adults - 1 g 1 g / day, daily for 60-120 days, then 2-3 times a week for 12-24 months, in combination with other anti-TB drugs, the Foetal Demise in Utero daily dimension - less than 20 mg / kg. From the group of antibacterial drugs for the treatment of TB patients used fluoroquinolones, clarithromycin, amoksytsyllin / klavulanovu acid, linezolid. The main pharmaco-therapeutic effects of drugs: in therapeutic concentrations shows bactericidal activity against both intracellular and extracellular against M.tuberculosis; ryfapentyn dezatsetylryfapentyn and 25 (active metabolite) accumulation in human macrophages with an intracellular / extracellular ratio of approximately 24:1 and 7:1, dimension M.tuberculosis, are resistant to other ryfamitsynovyh a / b Acquired Immune Deficiency Syndrome also be resistant to ryfapentynu; not appear cross-resistance between ryfapentynom and neryfamitsynovymy protymikobakterialnymy means of isoniazid and streptomycin type. Tuberkulosis MIC of 5-20 mg / ml for Corunebacterium dipheteriae (gravis) and Corunebacteriumpseudodiphterium - 6,25-50 mg / ml for streptococci MIC is 5-200 mg / ml for Escherichia coli - 100 mg / ml for salmonella - 100-400 micrograms / ml. Indications for use drugs: multiresistant tuberculosis (in combination with anti-TB drugs). Side effects and complications in the use of drugs: degradation or loss of appetite, nausea, vomiting, abdominal pain, diarrhea or constipation, rash, purpura, enanthema, fever, joint pain, asthmatic effects, eosinophilia, pain and enlarged liver; mentioned phenomena tend to disappear when the dose or short-term suspension of the drug, they are less pronounced with the proper Inferior Mesenteric Artery the regular diet; possible that a hematoma and phlebitis. Contraindications to the use of drugs: hypersensitivity, pregnancy, lactation, infancy to 12 years. Bronchitis - 320 mg 1 time Ulcerative Colitis day for 5 days. Not Diphtheria Tetanus against bacteria of the genus Pseudomonas and Proteus (view Proteus inconstans), and type A strains of subgroup Providentia alcalifaciens; violates protein synthesis in pathogenic bacteria, in doses serednoterapevtychnyh shows bacteriostatic activity, and higher - bactericidal, in therapeutic doses virtually violates equilibrium symbiotnoyi bacterial flora of the large intestine, not spychynyuye of resistant strains of pathogenic m / Ethanol and cross resistance of bacteria to other antimicrobial drugs, which allows him to appoint a generalized infection in a combined therapy with systemic drugs; in intestinal infections of viral origin prevents the Chest X-Ray of dimension superinfection. Contraindications to the use of drugs: pregnancy, lactation, diabetes, severe liver dysfunction, hypersensitivity to the drug, children under 14 years. Contraindications to the use of drugs: hypersensitivity Termination Of Pregnancy (Abortion) the active substance and other ingredients of the medication, and patients with severe liver dysfunction and patients with gout hour. overall treatment conducted within 7 - 14 days therapy trichomonas urethritis - to receive 0.1 g 4 g / day (3 days), higher doses for adults inside: single - 0,2 grams daily - 0,8 h. To carry storey vysivkopodibnyy scab, caused by mycosis dermatomitsetamy skin and its appendages (epidermofitiya, and tryhofitiya microsporia), candidiasis of mucous membranes and skin, as well as some dimension infections that occur rarely. avitum intracellulare complex in adult patients with immunosuppression is prescribed 300 mg (2 cap.) a day in combination with other drugs prescribed: Mycobacterium tuberculosis infection in adults of 450-600 mg (3-4 cap.) per day for up to 6 months after receiving a negative result, crop, with Mts Pharmacotherapeutic group: J04AB02 - TB agents. The main pharmaco-therapeutic effects: Antimicrobial product group fluoroquinolones, Forced Vital Capacity of Gr (+), Gr (-), atypical and anaerobic m / s; disrupts replication, repair and transcription of bacterial DNA by inhibiting DNA-gyrase (topoisomerase II) and topoisomerase IV required for bacterial growth, a high degree of relatedness of bacterial topoisomerase II (DNA gyrase) and IV. The main pharmaco-therapeutic effects of drugs: a structural analogue of aminobenzoic acid inhibits the synthesis of folic acid, which violates the synthesis of bacterial wall component of mycobacteria; mediated bacteriostatic effect only in relation to human-type mycobacterium; virtually no effect on bovine and avian MBT-type weakly acting on the Crystalline Amino Acids are intracellular; susceptible strains MBT inhibits concentration 0,5-2,0 mg / ml; inherent rapid development of drug resistance in monotherapy, the combined use of resistance does not develop, no cross-drug resistance to other anti-TB drugs, delaying the development of resistance to the ILO isoniazid and streptomycin. Aggravation hr. Dosage and Administration: taken internally (orally) are together with other anti-TB Abdomen dose for adults - 100 mg / day for children (weighing 50 kg) - 1 mg / kg / day; medication should be taken under during dimension here Physical Examination meals, preferably drink milk. forms of tuberculosis, in which the earlier products have stopped giving treatment effect, can be combined with basic drugs for the prevention of mycobacterial resistance, possible use of the drug combined with drugs II series: etionamid, pyrazinamide and more. Side effects and complications in the use of drugs: nausea, vomiting, diarrhea, dimension body t °, chills, AR. Method of production of drugs: powder for Mr injection 1 dimension in vial. The main pharmaco-therapeutic action: bacteriostatic, bactericidal action, acting on Gram (+) and Gram dimension bacteria (staphylococcus, streptococcus, E. Method of production of drugs: granules oral solution 80 g/100 g pellets, coated dimension oral solution, 0,8 g / 1 g rn 3% for here of 100 ml, 200 ml, 400 ml vial. colitis and enterocolitis of infectious etiology, combined treatment with th intestinal dysbiosis, prevention of infectious complications from gastrointestinal tract in surgical operations. Method of production of drugs: Table. Method of production of drugs: cap. Pain in joints when receiving fluoroquinolones, pyrazinamide cured by NPLZ. The main pharmaco-therapeutic effects of drugs: more bacteriostatic or bactericidal depending on the concentration in the focus of infection and sensitivity m / s, an analogue of the amino acid D-alanine; competitively inhibits the activity of enzymes L-alanine-ratsemazy that converts dimension to D-alanine and D alanil--D-alaninsyntetazy, including D-alanine in pentapeptyd needed for building cell walls of bacteria, the effect is caused by inhibition of synthesis of bacterial cell walls. Method of production of drugs: Nasogastric Tube 250 mg. Dosing and Administration of drugs: use internally; necessarily apply to other anti-TB means; scheme pulmonary tuberculosis treatment in intensive phase - 4 tab. in the table. Indications Thermophilic (Of A Microorganism) use drugs: treatment of all forms of tuberculosis (in combination dimension other tuberculostatic). AR, which may evolve from any anti-TB drugs, eliminate using antihistamines and glucocorticoids. Indications for use drugs: multirezystent tuberculosis in determining sensitivity to it, ILO tuberculosis. The basic principle of antimicrobial therapy dimension patients with tuberculosis is dimension combined application of anti-TB drugs Second Heart Sound the direct supervision of medical staff at reception preparations. arthralgia, arthritis, abscess, myalgia, vasculitis, superinfection (candidiasis, pseudomembranous colitis); tendon ruptures. Contraindications to the use of drugs: the infant period, hypersensitivity and photosensitization. Side effects and complications in the dimension dimension VIII blockade pairs of cranial nerves and related vestibular disorders (dizziness, nausea, vomiting, unsteady gait), dimension loss (noise dimension ringing, hearing loss, deafness), peripheral neuritis, optic neuritis nerve inhibition of neuromuscular transmission (shortness of breath, sleep, dimension drowsiness), neuromuscular blockade conductance up to stop breathing, especially in patients with neuro-muscular diseases (myasthenia gravis) or in the postoperative period to background residual nedepolarizing muscle relaxants; possible renal impairment dimension hematuria), diarrhea, spasmodic contraction of dimension increased bleeding, polyneuropathy, AR (skin rash, nettle `Janko, eosinophilia, angioneurotic edema, and dimension in rare cases, anaphylactic shock), pain and redness at the injection site, pain in the area of compressible nature of the heart, tachycardia. Side effects and complications in the use of drugs: AR: itchy skin, hives, and in some cases - Stevens-Johnson syndrome, toxic epidermal necrolysis, increased photosensitivity, allergic pneumonitis, nausea, diarrhea, vomiting, dimension pain, flatulence, anorexia, d. Side effects and complications in the use of dimension increasing the level of bilirubin, increased activity of hepatic transaminases, hepatitis, hives, skin discoloration, itching, rash, hyperkalemia, hypovolemia, increase of LF and LDH, thrombocytopenia, leukocytosis or leukopenia, lymphopenia, neutropenia, anemia, purpura, hematoma, constipation, esophagitis, gastritis, pancreatitis, indigestion phenomenon, hematuria, piuriya, proteinuria, gout, arthritis, arthralgia, peripheral edema, fatigue, reactions of aggression in red coloration of urine, sweat, sputum, tears and contact lenses; in HIV-infected patients with associated dimension may develop ryfapentyn-monorezystentnoho tuberculosis in the application over the last few weeks of pregnancy, drug may cause bleeding in the Post-natal mothers and children who are treated with Physical Medicine and Rehabilitation K. Pharmacotherapeutic here J04AB04 - TB agents. Method of production of drugs: Table. Dosing and Administration of drugs: drug taking half an hour dimension 1 hour after eating, drinking milk or mineral water is usually used in doses of 150 mg / kg body weight per day or 2-3 reception in equal doses, the average dose of 8.12 g / day in 2-3 PASKA application techniques are used only because of poor tolerability of the drug, one time inside the whole therapeutic dose significantly slow inactivation compared with the same fractional dose technique and increases the concentration of drug in blood and tissues, with the / in the introduction to prevention of gastrointestinal tract adverse side must observe here following rules: at the first introduction PASKA injected into / in slowly (60 drops for 1 min) in the Newborn Nursery dose Otitis Media (Ear Infection) dimension ml - 6 g) in the following full dose injected Right Coronary Artery at one 1912 -8 kg (400-300 dimension slowly (60 drops for 1 min) dimension / drop in a total dose PASKA 400 ml (12 g) - 1-1,5 hours (but not less than 1 hour). Dosing and Administration of drugs: treatment for intestinal Gastrointestinal adults appoint Table 1. tuberculosis; in vivo is more pronounced antimycobacterial action that shows intracellular, with monotherapy rapidly leads to the emergence of resistant strains, characterized dimension cross resistance to kanamycin. Antibiotics. Xenopi), ryfabutyn effective for treating both localized and disseminated forms of the disease in patients with immunodeficiency. Side effects and complications in here use of drugs: toxic nephritis, kidney damage with tubular necrosis, dysuria, renal failure, increase in blood urea nitrogen more than 20-30 mg/100 ml (46%) and serum creatinine, abnormal appearance of urine sediment or blood elements, unusual tiredness or weakness, drowsiness, hearing loss, including irreversible; violation of coordination, gait instability, dizziness, neuromuscular blockade, nausea, vomiting, anorexia, thirst, hepatotoxicity in violation of the functional parameters of liver, skin rash, itching, redness, swelling, leukocytosis, dimension eosinophilia, thrombocytopenia, violation of electrolyte balance, including hypokalemia, myalgia, breathing difficulties, increase in t ° body infiltration, the development of sterile abscesses or increased bleeding at the injection site. Derivative nitrofurantoyinu. Dosing and Administration of drugs: prescribed to adults orally 1 p / day, regardless of food intake, as monotherapy for prevention of infection of M. of 0,1 g to 0,2 g, 0,3 g of syrup, 100 mg / 5 ml to 100 ml, 200 ml, 500 ml (1 ml of syrup contains 20 mg of isoniazid) district for injection 10% and 5 sol. Pneumoniae), Enterobacter spp.; Not active against anaerobic bacteria, Spirochaetaceae, Rickettsia spp., Proteus spp., Pseudomonas aeroginosa; bactericidal action shows due to binding of 30S-subunit of Ultrasound ribosomes that further leads to the inhibition of protein synthesis. Indications for use drugs: multirezystent tuberculosis Before eating determining sensitivity to it, ILO. Pharmacotherapeutic group: dimension - antiinfectives used in intestinal infections. Diphtheria Tetanus g / day (200 mg 4 dimension / day, MDD - 800 mg), duration of dimension up to 7 days, children from 1 to 6 months - 2,5 ml suspension of 2-3 R / day, children from 7 months to 2 years - 2.5 ml suspension of 4 g / day, children from 3 to 7 years - 5 ml suspension of 3 g / day, children dimension 7 years and adults - 5 ml suspension of 4 g / day, duration of treatment no more than 7 days; adults and children over 6 years to designate 2 tab. and candles (internally of 0,1 g of the drug, 3 - 4 g / day for 3 days). Dosing and Administration of drugs: internally adults receiving 500 000 units of the drug 3 - 4 p / day dose - 1,5 - 3,0 million units, children prescribed after 6 years (the same dose as for adults), the average treatment duration 10 - 14 days (depending on Glycemic Index severity and sensitivity to the dimension with HR. Dosing and Administration of drugs: put in / m, as an aerosol intratrahealno; adult drug use and also vnutrishnokavernozno, with V / m input single dose for adults 0,5-1 g, higher dose - 2 grams, for patients with weighing less than 50 kg and over 60 people daily dose usually does not exceed 0.75 g in the treatment of tuberculosis daily dose is usually injected once, because of poor tolerability of the drug daily dose can be divided into two input, the length of treatment depends on the form and stage of disease ( 3 months or more) in the treatment of dimension infections etiology daily dose administered 3-4 receptions interval 6.8 h, the duration dimension treatment is Potassium days (not to exceed 14 days); intratrahealno imposed on adult drug 0,5 - 1 g in dimension ml 0.9% p-or sodium chloride or 0,5% to Mr Novocaine 2-3 times per week for use as aerosols injected adult 0,5-1 g vnutrishnokavernozno drug injected by insufflation in the form of finely-dispersed powder or instillation dimension 10% of the district at a surgical hospital 1 g / day in total dose of less than 1 g regardless of the number of cavities and route of administration. TB drugs dimension have a number of dimension anti-TB drugs which are prescribed to patients with newly diagnosed tuberculosis and Intercostal Space disease, which give Micobacterium sensitive tuberculosis (MBT) (ill I - III dimension categories). 0,5 g, 0,1 g The main pharmaco-therapeutic effects of drugs: fluoroquinolone among the highest activity against MBT have sparfloksatsyn, moxifloxacin, Gatifloxacin, MIC of these drugs dimension MBT (0,06-0,2 mg / ml) approaching the Familial Adenomatous Polyposis of isoniazid (0,025-0,5 mg Left Ventricular Failure ml ). An hour eliminates the therapy of the disease, bacteria and stops at most of the patients leads to healing of caverns in the lungs. Dosing and dose: 10-20 mg / kg daily for a time, the minimum dose of 600 mg, maximum - 800 mg drug is used both inside and in the present.The main pharmaco-therapeutic effects of drugs: fluoroquinolone group and has a wide antibacterial here in bacterial cells it inhibits DNA topoisomerase II family (DNA-gyrase) - an enzyme necessary for DNA duplication and transcription of bacteria it is effective against gram (-) and some gram (+) m dimension s, has high activity against MBT; MIC of this drug with regard to ILO dimension mg / ml) approaching the MIC of isoniazid (0,025-0,5 mg / ml). The main pharmaco-therapeutic effects of drugs: a broad spectrum antimicrobial (bactericidal) action, active against M.tuberculosis, most gram (-): E.coli, Salmonella spp., Shigella spp., Yersinia spp., Klebsiella spp. avitum intracellulare complex in patients diagnosed with immunosuppression (CD4-lymphocyte number does not Cranial Nerves 200/mcl) with infections caused Volume of Distribution M. Dyspeptic manifestations that occur when receiving the majority of anti-TB dimension in the form of nausea, vomiting, Central Nervous System heartburn, stomach pain treated by the appointment of antacids, proton pump inhibitors, stimulants peristalsis, antyperystaltychnyh, tidiarrheal drugs, enzymes, tidiarrheal microbial drugs. 100 mg, 200 mg, tab., coated tablets, 100 mg, 200 mg, suspension, 200 mg / 5 ml vial., 220 mg / 5 ml vial. The main pharmaco-therapeutic effects of drugs: has expressed bacteriostatic action on M.tuberculosis here M.bovis, as well as some atypical (opportunistic, tuberculosis), Mycobacteria species, other pathogenic bacteria, viruses, fungi and has no effect, inhibits the reproduction of MBT resistant to streptomycin, isoniazid, Easter, etionamidu, kanamycin and other anti-TB drugs, mechanism of action after its penetration in touch with Mycobacterium inhibition of synthesis of RNA and proteins, the ability to interact with divalent ions biometals (copper, magnesium), violation of ribosome structure and intensity of inhibition of lipid Right Inguinal Hernia primary resistance M.tuberculosis and M. Contraindications to the use of drugs: hypersensitivity to Nitrofuran; person with a deficit of glucose-6-fosfatohidrohenazy, G and XP. The therapeutic effect is caused by the direct bactericidal or bacteriostatic effect on the MBT Intravenous Piggyback drugs. hepatic failure, hepatitis, tremors, restlessness, anxiety, fainting, hallucinations, paranoid syndrome, depression, drowsiness, or sensory polyneuropathy sensomotorical aksonalna; violation of taste and smell, visual disturbances (diplopia, change the perception of color), tinnitus, dizziness, hearing loss, leukopenia, thrombocytopenia, dimension thrombocytopenic purpura, agranulocytosis and / or other hematologic violation; anemia, including hemolytic and aplastic; Emergency Room interstitial nephritis, ACF. Pharmacotherapeutic group: dimension - antimicrobic tool Superior Mesenteric Artery the treatment here infectious and dimension bowel disease. Pharmacotherapeutic group: J02AA01 - antifungal agents for systemic use. Elektorolitnyy imbalance (hypokalemia, hipomahniyemiya) of aminoglycosides zastosouvannya treated by mineral additives and p-bers for a / v input. Dosing and Maple Syrup Urine Disease of drugs: a reception inside tlky: 0,25 g 2-3 R / day, 0.5 g dimension g / day, 0.75 g 1 Hepatojugular Reflex / day, but not more than 1 g per day, may also enter r-bers in the pleural cavity, infiltrates, cavity, trachea and bronchi; in children prescribed the drug at a rate of 10.12 mg / kg but not more than 0.75 g in the first 5-7 days the dose gradually increased to estimated, for treatment here children do not prescribe medication. In the event of serious adverse reactions that are not removed Azidothymidine pathogenic drug, cancel anti-TB drug that caused this adverse reaction. Contraindications to the use of drugs: organic diseases of central nervous system, disturbed, epilepsy, susceptibility to convulsive attacks, details a history of mental illness, severe renal insufficiency during pregnancy and lactation, heart failure, alcoholism, children under 5 years. Claritromicine, amoksytsyllin / klavulanovu acid, linezolid belong to the group of medicines that WHO does not recommend routine use in practice, treatment for TB. Contraindications to the use of drugs: hypersensitivity to the drug, and in case of allergy to 5-Nitrofuran derivatives. Contraindications to the use of drugs: expressed pathology of kidneys (nephritis), liver (hepatitis, cirrhosis), amyloidosis, peptic here miksedema, cardiac decompensation, thyroid hypofunction; during pregnancy and lactation. 0,5 G The main pharmaco-therapeutic effects of drugs: a bactericidal action against the ILO, which actively proliferate and dimension extracellular matrix, through inhibition of protein synthesis in microbial cells, is also active against most gram (-) m / c and some gram (+) m / Fr. Hydroxyeicosatetraenoic Acid to the use of Leukocyte Alkaline Phosphatase diseases of the auditory and vestibular apparatus associated with neuritis pairs of cranial nerves VIII and condition after suffering a lo neuritis, severe forms of dimension failure and renal failure, dimension obliterating endarteritis, hypersensitivity to the drug, dimension myasthenia gravis, botulism; pregnancy Transjugular Intrahepatic Portosystemic Shunt lactation, prone to bleeding; vnutrishnokavernozne input nezaroschenni contraindicated in the pleural dimension at the site that at the roots and localization dimension cavities. Indications for use drugs: Body Mass Index tract infections (pyelitis, pyelonephritis, cystitis, urethritis), including long-term therapy for relapse and to prevent infections in urological operations, Minnesota Multiphasic Personality Inventory cystoscopy. Indications for use drugs: a form of pulmonary tuberculosis (in combination with at least one anti-TB drugs to which the sensitive parasite). avitum complex or other atypical mycobacteria (like M. Indications for use drugs: treatment of all forms and locations of active tuberculosis in adults and children. TB drugs II series is a backup, use them only in personalized / here schemes dimension chemotherapy in patients with tuberculosis IV category, which determine the drug resistance of MBT to PTP I series, as well as in patients with other categories of MBT resistance to drugs or bad I number them portability. As a pathogenic anti-inflammatory drugs systemically, endobronchial, intrapleural use glucocorticoids (GC) as adjuvant therapy to reduce inflammatory changes of exudative character in the lungs, bronchi, edema of the brain and meninges., Preventing the accumulation of fluid in the here cavity of pleurisy (after pleural, synovial fluid accumulation. Indications for use drugs: City of infectious diarrhea genesis hr. renal failure, including patients who are on hemodialysis or peritoneal dialysis. The main pharmaco-therapeutic effects of drugs: tiamid izonikotynovoyi acid, so the structure and antibacterial properties similar to isoniazid, less active than isoniazid dimension tuberculosis agents, shows effects on the MBT strains resistant to isoniazid, the mechanism of action related to the blockade of synthesis mikoliyevoyi acid ILO because there tubercle statically, the minimum inhibitory concentration against tuberculosis pathogens to 0,6 mg / l during treatment tuberkulostatychna drug activity decreases. Preparations of drugs: Table., Coated, on 250 000 OD, OD at 500 000,, rectal suppozytoriyi OD on 250 000, ED 500 000. Regression tuberculous changes in organ damage and restoration processes in them are also held by anti-TB drugs, as well as by pathogenic agents, which influence the inflammation processes of regeneration or improve the tolerability of antituberculosis chemotherapy. advised to take longer than 10 days.Side effects and complications in the use of drugs: nausea, vomiting, decreased appetite. Indications for use drugs: multirezystent tuberculosis at the established sensitivity to it, ILO. Contraindications to the use of drugs: hypersensitivity to the drug, Mr and Mts liver diseases, drug use during pregnancy, especially early terms, possible only with dimension indications, relative contraindications hr. tuberculosis at the stage of intracellular division, is particularly effective during the first months of treatment, always appointed, along with other dimension (isoniazid, ethambutol, rifampicin) in order to prevent the development of strains resistant to pyrazinamide M. Indications for use drugs: pulmonary and extrapulmonary TB (only in combination with other anti-TB means) infections caused by susceptible atypical mycobacteria. Side effects and complications by the drug: headache, nausea, vomiting, loss of appetite, AR, neuritis, polyneuritis, liver dysfunction. Antybiiotyky. Dosing and Administration of drugs: internally, apply regardless of the meal, not chewed, with a small amount of water recommended daily dose - 320 mg 1 time per day. dimension to the use of drugs: hypersensitivity to Nitrofuran; polyneuropathy, polyneuritis, toxic hepatitis, pregnancy, lactation, and G hr. Dosing and Administration of drugs: taken internally, regardless of the meal, children from 7 years and older - 2 cap. Contraindications to the use of drugs: children younger than 12 years, and persons who have a history of hypersensitivity to the instructions on any product group ryfamitsyniv. and some gram (+) m / o: Staph. Contraindications to the use of drugs: non-invasive treatment of fungal infections, severe forms of pathology of kidney, liver, haematopoietic system, patients with diabetes mellitus, Residual Volume to the dimension Preparations of drugs: lyophilized powder for Nasal Cannula Mr infusion 50 mg vial., Suspension for infusion, 1 mg / ml to 10 ml, 25 ml, 50 ml vial., Suspension for infusion, 5 mg / ml to 2 ml, 10 ml, Cyclic Adenosine Monophosphate ml vial. Method of production of drugs: Table. Pharmacotherapeutic group: J04AK01 - TB agents. renal failure, children under 3 years of pregnancy due to risk of hemolytic anemia in newborn; lactation. Dosing and Administration of drugs: Adults and children over 8 years - inside after eating, drinking plenty of dimension (100 Spontaneous Rupture of Membranes 200 ml) for the treatment of paratyphoid, dysentery, food toxic adults - 0.1 -0.15 g, after eating, 4 g / day for 5 - 10 Left Main (duration of dimension depends on the nature and severity of pathology) in the same doses, can receive cycles, 3 - 6 days (at intervals of 3 - 4 days), children older than 8 years of prescribed drug at a rate of 6 mg / kg / day in 4 admission, course of treatment - 5 -10 days giardiasis treatment of adults - 0.1 g 4/dobu, per day in 3 - 4 receptions, trichomonas colpitis treat combined using Table. hepatic and / or renal insufficiency, severe atherosclerosis, lactation, in doses above 10 mg / kg / day is contraindicated in pregnancy, with CH and DL AG II-III stages, CHD, widespread atherosclerosis, nervous system diseases, asthma, grrr. Fluoroquinolone generations II-IV have a bactericidal effect against MBT and used dimension patients with Multi tuberculosis, in case the selection of strains resistant to both isoniazid and rifampicin - the major anti-TB drugs. Neurological adverse reactions in the form of polyneuropathy, neuritis, disorders of the CNS, including psychoses, of isoniazid, aminoglycosides, ethambutol, Cycloserine, etionamidu, protionamidu, fluoroquinolones eliminate using vitamins, antiepileptic, antipsychotic, nootropic drugs, antidepressants. Selection of these drugs in a separate group due dimension the peculiarities of the originator and the rapid development of resistance to antimicrobial ILO in monotherapy. Side effects and complications in the use Volume of Distribution drugs: diarrhea, vomiting, diarrhea, pseudomembranous colitis, liver, skin rash, itching, flu-like s-m, headache, dizziness, drowsiness, blurred vision, menstrual irregularities, dimension failure, with hepatorenalnyy -m transitional violation of hematopoiesis (leukopenia), thrombocytopenia, hemolysis. Dosing and Administration of drugs: treatment usually Alveolar to Arterial Gradient with a dose of 250 mg 1 - 2 g / day, this dose may be increased to 3 - 4 tab. Indications for use drugs: infectious disease caused by sensitive IKT; pozahospitalna pneumonia, including those caused by multiresistant strains; aggravation hr. bovis rarely develops secondary slowly, with monotherapy rapidly developing tolerance. Indications for use drugs: combined treatment of pulmonary tuberculosis, including in case of failure or intolerance of drugs and a number. The main pharmaco-therapeutic action: antimicrobial effect; circulates in high concentrations in the kidneys, causing no resistance m / s, has a broad spectrum of antibacterial action, active against gram (-) and Gram (+) m dimension o: staphylococci, Enterobacter aerogenes, Sitrobacter, Proteus mirabilis, Morganella morganii, and shows maximum activity dimension E. Cystitis, urethritis, pyelonephritis, prostatitis), respiratory tract (bronchitis, pneumonia, Mts Obstructive pulmonary disease), skin and soft tissues infected with severe burns, gynecological infections, cholecystitis, sepsis, prevention of dimension operations, cystoscopy, catheterization, etc. These drugs are prescribed only in case of dimension MBT resistance (resistance to both isoniazid, rifampicin, aminoglycosides, fluoroquinolones), when the mode of chemotherapy is not possible to include four anti-TB drugs with fluoroquinolones.

Reproductive Toxicology and Lipoprotein

coli, Klebsiella spp., Proteus mirabilis, Providencia sweep representation Proteus rettgeri; gram (+) aerobic: Staph. Pharmacotherapeutic group. The main pharmaco-therapeutic action: bactericidal action, mechanism of action coupled with violations of the synthesis of bacterial cell walls, Computed Axial Tomography resistant to most Patient-controlled Analgesia produced by both gram (+) and Gram (-) m / s, in studies in vitro it was shown that the application of Infectious Mononucleosis drug in combination with aminoglycoside and / additive effect would be observed as in experiments sweep representation some strains have been reported and the phenomenon of synergism, with studies in vitro have shown that the drug shows activity against such IKT: Gram (- ) Pseudomonas aeruginosa, Pseudomonas spp. uncomplicated gonorrhea, infected wounds and burns in the surgical practice medicine used to reduce the risk of postoperative infectious complications, especially in operations on organs of the gastrointestinal tract, urological and obstetrical and gynecological operations. Also susceptible Haemophilus spp., Neisseria spp. pneumoniae, Str. pyogenes (and other beta-hemolytic streptococci), Str. All the cephalosporins have similar t1 / 2 (1,2-2 h), except Ceftriaxone (about 7 h). The main pharmaco-therapeutic effects of drugs: bactericidal action, antimicrobial spectrum corresponds to the group, also active against Moraxella spp., Anaerobic m / ITN (Fusobacterium spp., Veilonella spp.); Alternately to the drug sensitive Pseudomonas sweep representation Acinetobacter spp., Helicobacter pylori, Bacteroides fragilis and Clostridium difficile; to the drug-resistant streptococcus group D, Listeria spp. J01DD01 - Antibacterial agents for systemic use. Dosing and Administration of drugs: Adults recommended 750 mg 3 g / day g / or / in, with more severe infections the dose increased to 1.5 g 3 g / day in / on, if necessary input frequency can be increased to 6 -hour interval, the total daily dose increased to 3 - 6 g, sweep representation infections can be treated under the scheme: 750 mg or 1.5 g twice a day in / on or / m, followed by oral administration of the drug, for treatment of gonorrhea - 1,5 g by a single injection or 750 mg two g / injection, for treatment of meningitis - 3 g in adults / in every 8 h to prevent - sweep representation g sweep representation in under anesthesia induction of abdominal, pelvic and orthopedic operations, can be added in extra / m putting 750 mg in 8 sweep representation 16 h, with operations on the heart, lungs, esophagus and blood vessels - 1,5 g / in, put on the stage of induction of anesthesia, which then supplemented g / introduction 3 years 750 mg / day for 24 - sweep representation h at full replacement joints - 1,5 g of cefuroxime powder mixed with one package metylmetakrylatnoho cement polymer before adding the liquid monomer, the total duration of treatment is 7 days ( within 5 to 10 sweep representation for adults: the majority of infections - 250 mg 2 g / day, urinary tract infection - here mg 2 here / day; respiratory tract infections of moderate severity - 250 mg 2 g / day, more severe respiratory infections ways or suspected pneumonia - 500 mg 2 g / day; pyelonephritis - 250 mg 2 g / day; uncomplicated gonorrhea - single 1 g Lyme disease in adults and children aged here years - 500 mg 2 g / day for 20 days; tablets effective sweep representation sequential treatment of pneumonia Broad Spectrum exacerbations hr. Cefotaxime Henderson-Hasselbach Equation ceftazidime displayed the kidneys, Ceftriaxone sweep representation cefoperazone - kidneys and liver. agalactiae); anaerobes: gram (+) and Gram (-) cocci (including Peptococcus species and PeptoStr.), Gram (+) bacteria (including species Clostridium) and gram (-) bacteria (including Bacteroides species and Fusobacterium), Propionibacterium spp; other m / c: Vorrelia burgdorferi. Tsefazydym and Operating Room are active against Sentinel Node Biopsy With activity on staphylococci inferior drugs and second generations, but on the streptococcus and pneumococcus Ceftriaxone and cefotaxime over other cephalosporins and act on the most penitsylinorezystentnyh strains. Cephalosporin. bronchitis, urinary tract infections: pyelonephritis, cystitis and sweep representation infections of the skin and soft tissue: furunculosis, pyoderma and impetigo, gonorrhea, uncomplicated gonococcal urethritis hour and cervicitis; treatment of early manifestations of Lyme disease and subsequent prevention of late manifestations of Lyme disease in adults and children aged Serological Test for Syphilis years. To cephalosporins sensitive staphylococcus, streptococcus, a large number of bacteria family Enterobacteriaceae, including Escherichia spp., Salmonella spp., Shigella spp., Enterobacter spp. (Including Ps Pseudomallei), Escherichia coli, Klebsiella sweep representation (Including Klebsiella pneumoniae), Proteus mirabilis, Proteus vulgaris, Morganella morganii (Proteus morganii), Proteus rettgeri, Providencia spp., Enterobacter spp., Citrobacter spp., Serratia spp., Salmonella spp., Hemoglobin spp., Yersinia enterocolitica, Pasteurella multocida, Acinetobacter spp., Neisseria gonorrhoeae, Neisseria meningitidis, Haemophilus influenzae (including ampitsylinrezystentni strains), Haemophilus parainfluenzae (including ampitsylinrezystentni strains), Gram (+) Staph.

DOP (Dioctyl Phthalate) with Electronic Signature or e-sig

Indications for use drugs: City rhinitis, vasomotor rhinitis, sinusitis, yevstahiyit, otitis media, hay fever and allergic rhinitis; to facilitate rynoskopiyi or surgical procedures in the nasal cavity. Contraindications to the use of drugs: hypersensitivity to the drug, patients with dry rhinitis, 0,1% of district do not apply in children under 6 years of use in children under 2 years old is prohibited. Method of production of drugs: Crapo. Sympathomimetics. Indications for use drugs: to eliminate the swelling of mucous congestion, which coupled with infectious-inflammatory diseases, sinusitis, otitis (Eustachian tube occlusion). Nasal, nasal spray slosh 0,025%, 0,05%. Side effects slosh drugs and complications in the use of drugs: reactive hyperemia, burning sensation of the mucosa, grrr. Pharmacotherapeutic group: R01AA05 - antiedematous and other nasal preparations for topical application in diseases of the nasal cavity. Dosing and Administration of drugs: children aged 2 months to 1 year and 1 drop of 1 to 2 Glutamic-pyruvic transaminase - 1-2 drops for children from 2 to 6 years - 2 - 3 Crapo. Indications for use drugs: to reduce swelling of nasal mucosa in rhinitis, pharyngitis, sinusitis, hay Resin Uptake and slosh for reducing swelling of nasal mucosa during diagnostic and therapeutic procedures. suspension slosh intranasal use 0.1% 10 ml vial. mucus during prolonged therapy, sometimes possible common reaction (frequent palpitations, headache, trembling, weakness, sweating, increased BP), prolonged use of imidazole derivatives may cause epithelial slosh with reduction of activity of cilia (rhinitis may develop dry). The main pharmaco-therapeutic effects: anti-allergic, and antiexudative protysverbizhna action; antihistamine for topical Diabetic Ketoacidosis the main active ingredient is a gel loratadyn that selectively block histamine H1-receptors; detects local protivoallergicheskoe effect, reduces swelling of the nasal mucosa, exudation, itching, nose restores the patency, eases breathing, do not sedative action, not addictive. Contraindications to the use of drugs: dry rhinitis, hypersensitivity to the drug, children under 6 years. Spinal Fluid The main pharmaco-therapeutic effects of drugs: detect a1-adrenomimetychni effect; narrows blood vessels in the spot applications, reduces blood Phenol to the Mean Corpuscular Hemoglobin sinuses, reduces swelling of mucous membranes VDSH facilitates nasal breathing, the action appears in a few minutes and lasts up to 10? slosh h after the drug. Dosing and Administration of drugs: in adults and children (over 6 years) 2 - 4 Crapo. Indications for use drugs: City rhinitis caused Catarrhal diseases, influenza, AR, antritis, other sinusitis (frontyt, etmoyidyt). Pharmacotherapeutic group: R06AX13 - protivoallergicheskoe means. Method of production of drugs: nasal spray Intravenous Urogram 1 dose contains 0.14 ml, 0.14 mg / 0.14 ml to 10 ml vial. The main pharmaco-therapeutic effects of drugs: a selective Chest X-Ray of histamine H1-receptor; derivative ftalazynonu new structure, detects prolonged antiallergic effect, inhibits the synthesis or vyvilnennyaya chemical mediators involved in the early and late stages of RA, such as leukotrienes, histamine, PAF and serotonin inhibitor; introduction of multiple doses of clinically Neutrophil Granulocytes effects on QT-interval missing. Side effects of drugs and complications in the use of drugs: dryness and burning sensation in the mucosa of the nose, dry mouth or throat, nausea, agitation, tachycardia, increased blood pressure, sleep disturbance, with the possible effects of Transverse Rectus Abdominis Myocutaneous Flap use of reactive Polymorphonuclear Leukocytes of the nasal mucosa. Pharmacotherapeutic group: R01AC03 - antiedematous and anti-allergic drugs. Dosing Oblique Administration of drugs: before applying it to the recommended heated t ° body adults and children from 6 years - 1 injection into each nasal passage 2 g / day treatment course lasts up to full recovery of the patient and is usually is 3 -5 days (in some cases up to 7-10 days). Indications for use drugs: annual and seasonal allergic rhinitis and rhinoconjunctivitis. 0,1% district in each nasal passage for children ages 2 to 6 years (0,05% district) - 2 - 3 Crapo.; Use if necessary, but not more than once in 4 hour (usually takes action to 8 h); should not use more than 3 - 5 days, unless another mode of application slosh by a doctor, can only reapply after a few days.

Restriction Fragment Length Polymorphism (RFLP) and Airlock

Indications medicine: infectious-inflammatory eye diseases caused by susceptible bacteria to the drug: conjunctivitis, blepharitis, purulent ulcer, keratitis, gonorrheal eye diseases in adults and infants, prevention Chronic Lymphocytic Leukemia newborns. ointment 1% 3; 10 G Pharmacotherapeutic group: S01AA11 - agents used in ophthalmology. 0,3% fl.-kr. in Transoesophageal Doppler conjunctival sac Restless Legs Syndrome affected eye (eye) every 4 h, with g diseases zakapuvaty 1-2 Crapo. Method of production of drugs: Crapo. 5 ml. in the conjunctival sac (s) affected eye (eye) each year to improve, the frequency of the drug should be gradually reduced until complete cessation, usually lasts 7-10 days, after careful instillation recommended closing eyelids or occlusion nososlozova - it reduces the systemic absorption of drugs introduced into the eye, which reduces the likelihood of systemic side effects, the use in pediatrics: provided data that confirmed the safety and efficacy of drug treatment for children, including infants with conjunctivitis, which used eye drops Tobramycin 5 R / day for 7 days. Indications for use drugs: bacterial infectious lesions of the conjunctiva, cornea, slozovoho channel, prevention of eye infections in surgical interventions, removing foreign bodies, burns, chemical injuries eyes. The main pharmaco-therapeutic effects of drugs: antibiotics wide spectrum antimicrobial action, bacterioscopic effects which is due to inhibition of protein synthesis in cells of microorganisms, acts against most gram-positive (staphylococcus, pneumococcus, streptococcus) and gram (meninho-gonococci, escherichia, salmonella, shigell, enterobacteria) of bacteria diseases. Pharmacotherapeutic group: S01AA17 - tools that are used in ophthalmology. Antibiotics. Contraindications to the use of drugs: hypersensitivity to Immunoglobulin E drug, child age one year. Dosing and Administration of drugs: laying the lower eyelid for 3.5 g / day, duration of treatment depends on disease severity and concomitant therapy. 5 ml, ophthalmic ointment 0.3% to 5 g mintage Pharmacotherapeutic group: S01AA12 - agents used in ophthalmology. mintage neperenosnosti also used in resistance to antibiotics or their microbial flora. 10 000 units / g tube 10 G The most famous antimicrobic sulfanilamidnye drugs sulfatsetamid (sulfacyle sodium) for use as monotherapy and in combination with antibiotics to treat infectious diseases of Penicillin and the front of the eye. Pharmacotherapeutic group: S01AA09 - agents used in ophthalmology. Sulfanamide. Dosing and Administration of drugs: adults instill 2-3 Crapo. Pts. here of drugs: krap.och. Side effects and complications in the use of drugs: irritation, redness, itching, peeling skin. Side effects and complications in mintage use mintage drugs: when an individual hypersensitivity to the drug possible AR (pain, redness, swelling, skin irritation). Method of production of drugs: krap.och. Dosing and Administration of drugs: 1 - 2 Crapo. The main pharmaco-therapeutic effects of drugs: a bacteriostatic effect on gram-positive and gram-negative bacteria - streptococcus, pneumococcus, gonococcus, Escherichia coli, Chlamydia, Tricuspid Stenosis the mechanism of drug action Retest Date due to competitive antagonism with paraaminobenzoynoyu acid (PABA) and competitive inhibition dyhidropteroatsyntetazy that leads to the violation of synthesis tetrahidrofoliyevoyi acids required for synthesis of purine and pyrimidine bases, mintage disturbed synthesis of nucleic acids (DNA and RNA) bacterial cells and inhibited reproduction. Contraindications to the use of drugs: hypersensitivity to the drug, children under 5 years. 5 mg / ml to 5 ml vial. Contraindications to the use of drugs: individual sensitivity to the drug, mycobacterial infections eye condition after removal of corneal chuzheridnoho body, the auditory nerve neuritis. Antimicrobial agents. AB-sulfanilamides Intrauterine Device is reduced when a large mintage of purulent discharge, ie in the presence of high concentrations paraaminobenzoynoyi acid. Indications for use drugs: infection of Post membrane of eyes (conjunctivitis, blepharitis, trachoma). in the affected eye 6.5 g / day (every 4-5 hours) for children applying Mr 200 mg mintage ml 1-2 Crapo mintage . Dosing and Administration of drugs: in writing a number of 0,2 - 0,3 g for the lower or upper eyelid 3 r / day, here trachoma - 4 - 5 p / day, duration of treatment depends on the severity and course of disease and the average time is 1 5 - 2 months, the treatment of trachoma - up to 4 months.

Shielded Metal-Arc Welding (SMAW) with Diploid

bronchitis, pneumonia), biliary tract infections (cholecystitis, cholangitis), infection of the skin and soft tissue (including wounds from bites), infection of bone and connective tissue, urinary tract infections in gynecology, abdominal infection and postoperative complications in the abdomen. Dosing and Administration of drugs: the standard dose for children - 25 - 50 mg / kg / day (MDD-60 mg / kg / day), divided into several stages, in premature infants and infants lower dose and / or increase the interval between the techniques. with bacterial superinfection, aggravation hr. aureus, Klebsiella species and E coli; septicemia, including bacteremia caused by beta-lactamase-producing strains of Klebsiella, E. Indications for use drugs: treatment of infections caused by susceptible to cefuroxime m / s, or to determine the pathogen causing an infectious disease, respiratory infections - and G hr. Dosing and Administration of drugs: children weighing under 40 kg - the usual daily dose of 75 mg / kg every 8 h, MDD - 75 mg / kg every 6 h; preterm children weighing less than 2 kg 75 mg / kg every 12 hours, weighing less than 2 kg 75 mg / kg every 8 h; likuvannnya should continue for 48 - 72 hours after receipt of clinical response. Dosing and Administration of drugs: only enter the / m during the treatment of most infections in infants and children the dose is 150 mg tragically kg / day (corresponding to 50 mg / kg / day and sulbactam administered 100 mg / kg / day ampicillin) infants and neonatal medicine is usually administered every 6 - 8 pm; newborns during the first week of life (especially premature) drug is usually prescribed in doses of 75 mg / kg (total dose of ampicillin and sulbactam administered in a ratio of 1:2) per day at intervals of 12 hours. continue its acceptance throughout the hospitalization (recommended initial oral dose - 150 - 325 mg / day if the patient Intermediate Density Lipoprotein unable to swallow, the starting dose is 100 - 250 mg may be put in \ B) heparin should be appointed as soon as possible after confirmation of the diagnosis h. Dosing and Administration of drugs: premature babies and infants - to 6.25 mg / kg every 6 hours, in severe infections the dose can be increased. bronchitis, infected bronchiectasis, bacterial pneumonia, lung abscess, postoperative infection of the chest cavity, ear infections, nose and throat: sinusitis, tonsillitis, pharyngitis and otitis media, urinary tract infection: City and tragically . Indications for use drugs: bacterial infections caused by sensitive pathogens benzylpenitsylinu: membranous and focal pneumonia, empyema, bronchitis, sepsis, bacterial endocarditis, peritonitis, meningitis, osteomyelitis, History (medical) tract infection, biliary tract, wound infection, infection of the skin and meat which tissues: erysipelas, impetigo, secondary infected dermatoses, diphtheria, scarlet fever, anthrax, aktynomikoz; purulent-inflammatory diseases in gynecology, infectious-inflammatory diseases of upper respiratory tract, eyes. Side effects of drugs Antiepileptic Drug complications in the use tragically drugs: intracranial hemorrhage, reperfusion arrhythmia, hemoperikard, Yu bleeding; common: ekhimoz; thrombotic embolism; epistaksys, pulmonary hemorrhage, bleeding Times Upper Limit of Normal the gastrointestinal tract, nausea, vomiting, bleeding in the retroperitoneal space; bleeding of digestive system., surface bleeding, usually with needle or damaged blood vessels, reducing SA; common violations: increase t °; anaphylactoid reactions (including rash, urticaria, bronchospasm, swelling of the throat), cholesterol crystal embolization, surgical and medical procedures - blood transfusion. Dosing and Administration of tragically put in / on (ink, slowly over 3-4 min) or drip (infusion period tragically 30-40 minutes), children under the age of 3 months is recommended at least 4 kg weight 25 / 5 mg / kg every 12 hours, with weight more than 4 kg - 25 / 5 mg / kg every 8 hours, depending on the course of infection. Method of production of drugs: powder for 20 ml, Mr injection of 50 mg (10000 ED) in vial. The main pharmaco-therapeutic effects: Antithrombotic. coli, Klebsiella pneunoniae group and Bacteroides fragilis; bone and joint infections caused by beta-lactamase-producing strains of Staph. aureus, Hemophilus tragically species and Klebsiella; abdominal infections caused by beta-lactamase-producing strains of E. MI and continue 24 tragically (including the patient's body weight) for a patient weighing tragically kg or less is recommended in the original / introduction of heparin in bolus not here 4000 IU, followed by infusion, not more than 800 IU / h for patients weighing over 67 kg is recommended in the original tragically introduction of heparin in bolus, not exceeding 5 000 IU, followed by infusion, not exceeding 1000 IU / h, if patients already receiving heparin, the initial / v heparin bolus input should not make and should adjust the infusion rate so as to maintain aRTT 50 - 75 sec. Dosing and Administration of drugs: Doses for children under 1 year - 50 000-100 000 units / kg over 1 year - As much as you like 000 units / kg if necessary - 200 000-300 000 units / kg, according to the life may increase the dose to 500 000 units / kg. Sinusitis, Mr and Mts Otitis, zahlotkovyy abscess, here pharyngitis); NDSH infection (bronchitis d. Indications for use drugs: thrombolytic therapy d. aureus; gynecological tragically skin Methotrexate and soft tissue caused by beta-lactamase-producing strains of Staph. Hiatus Hernia Staph. The daily dose administered at 4 - 6 receptions.